Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People

Not Applicable

Completed

• Conditions: Cold; Fatigue Syndrome, Chronic

• Registration Number: NCT05728918
• Lead Sponsor: Greenyn Biotechnology Co., Ltd.

Brief Summary

This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people.

Detailed Description

This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people: a randomized, double-blind, placebo-controlled, and parallel clinical investigation.

Study Timeline

• Study First Submitted: 2023-02-01
• Study First Submitted QC: 2023-02-12
• Study First Posted: 2023-02-15
• Study Start: 2023-03-01
• Primary Completion: 2024-02-29
• Study Completion: 2024-05-30
• Status Verified: 2024-08
• Last Update Submitted: 2024-08-07
• Last Update Posted: 2024-08-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

• Subjects are easy to feel fatigued
• Subjects have poor sleep quality

Exclusion Criteria

• Pregnant women or preparing for pregnancy.
• Lactating women.
• Women gave birth 6 months before the study.
• Poor kindy and livers funcitons
• Severe cardiovascular or other chronic diseases
• Alcohol abuser
• Using immune-associated supplements

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Immune analysis	Baseline up to 4 weeks	Changes in B cell markers of 29 participants will be analyzed between baseline and week 4.
Cytokine analysis	Baseline up to 4 weeks	Changes in TNF-alpha levels of 29 participants will be analyzed between baseline and week 4.
Antibody analysis	Baseline up to 4 weeks	Changes in IgM levels of 29 participants will be analyzed between baseline and week 4.

Trial Locations

Locations (1)

WanFang Hospital; 🇨🇳 Taipei, Taiwan